CRT 2026

Cardiotube Interview: LBCT: Drug-carrier-based Sirolimus-eluting Stents Versus Zotarolimus-eluting Stents In Patients With Diabetes: 5-year Follow-up Of The Sugar Randomized Controlled Trial

Interviewer(s)

• 

  C. Michael Gibson, MD

  Professor of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.

Interviewee(s)

• RR

  Rafael Romaguera, MD, PhD

  Staff
  Hospital Universitari de Bellvitge
  L'Hospitalet de Llobregat, Catalonia, Spain

  Disclosure information not submitted.